Benitec Biopharma Inc.

BNTCNASDAQHealthcare● Active

$10.59

+$0.04(+0.40%)

Market Cap$278021835

P/E Ratio—

52W High$17.15

52W Low$9.85

Avg Volume128K

Open$10.70

Beta0.28

Net Income Financials Revenue

Benitec Biopharma Inc. (BNTC) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BNTC · net income · updated Jun 8, 2026

Core profitability metrics

BNTC · net income · margin · TTM · CAGR

Net income was −$37.9M for FY2025 (fiscal year ending 2025-06-30), down 74.3% year-over-year. Net profit margin was —. Based on available data, Benitec Biopharma Inc. has been profitable since at least 2019.

FY2025 Net Income−$37.9M▼ -74.3% YoY

Trailing 12M (TTM)−$48.9Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-74.3%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · BNTC net income history · BNTC profit margin

Annual net income data

BNTC · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$37.9M▼ 74.3%—$0

FY2024Loss−$21.8M▼ 11.2%—$0

FY2023Loss−$19.6M▼ 7.4%-26082.7%$75,000

FY2022Loss−$18.2M▼ 31.2%-24942.5%$73,000

FY2021Loss−$13.9M▼ 67.8%-23528.8%$59,000

Net income vs peers (Healthcare)

BNTC vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Benitec Biopharma Inc.YOU

BNTC

−$37.9M-74.3%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Benitec Biopharma Inc. (BNTC) reported net income of −$37.9M for FY2025 (fiscal year ending 2025-06-30), down 74.3% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Benitec Biopharma Inc. has been profitable since at least 2019. Net income reached a peak of $1.8M in FY2019. Data available for 15 fiscal years.

Benitec Biopharma Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Benitec Biopharma Inc. net worth" — the company's market capitalization is a separate figure from BNTC net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BNTC net income · 4 questions

Benitec Biopharma Inc. is not currently profitable on an annual basis. The company reported a net loss of $37.9M for FY2025.

is BNTC profitabledoes BNTC make a profitBNTC profitabilityBNTC profitable company

▸ Source: FMP /income-statement · GAAP · Benitec Biopharma Inc. · Benitec Biopharma Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026